These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25888602)

  • 1. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.
    Giustiniani J; Guillemeau K; Dounane O; Sardin E; Huvent I; Schmitt A; Hamdane M; Buée L; Landrieu I; Lippens G; Baulieu EE; Chambraud B
    FASEB J; 2015 Aug; 29(8):3171-81. PubMed ID: 25888602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-cleaved Tau-D(421) is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons.
    Meduri G; Guillemeau K; Dounane O; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE; Giustiniani J
    Neurobiol Aging; 2016 Oct; 46():124-37. PubMed ID: 27479154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17.
    Giustiniani J; Sineus M; Sardin E; Dounane O; Panchal M; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE
    J Alzheimers Dis; 2012; 29(2):471-83. PubMed ID: 22233767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isomerization and Oligomerization of Truncated and Mutated Tau Forms by FKBP52 are Independent Processes.
    Kamah A; Cantrelle FX; Huvent I; Giustiniani J; Guillemeau K; Byrne C; Jacquot Y; Landrieu I; Baulieu EE; Smet C; Chambraud B; Lippens G
    J Mol Biol; 2016 Mar; 428(6):1080-1090. PubMed ID: 26903089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
    Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
    Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophilin FKBP52 induces Tau-P301L filamentous assembly in vitro and modulates its activity in a model of tauopathy.
    Giustiniani J; Chambraud B; Sardin E; Dounane O; Guillemeau K; Nakatani H; Paquet D; Kamah A; Landrieu I; Lippens G; Baulieu EE; Tawk M
    Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4584-9. PubMed ID: 24623856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for FKBP52 in Tau protein function.
    Chambraud B; Sardin E; Giustiniani J; Dounane O; Schumacher M; Goedert M; Baulieu EE
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2658-63. PubMed ID: 20133804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
    Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
    Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
    Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
    Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation.
    Chambraud B; Belabes H; Fontaine-Lenoir V; Fellous A; Baulieu EE
    FASEB J; 2007 Sep; 21(11):2787-97. PubMed ID: 17435176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of WO2011045166A1, Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction.
    Zheng F; Zhang B; Sun Y; Qiu M; Su J
    Expert Opin Ther Pat; 2015 Jul; 25(7):831-5. PubMed ID: 25945965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    Meduri G; Guillemeau K; Daguinot C; Dounane O; Genet M; Ferrara L; Chambraud B; Baulieu EE; Giustiniani J
    J Alzheimers Dis; 2023; 94(1):313-331. PubMed ID: 37248902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
    Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
    Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
    Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
    J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.
    Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G
    Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.
    Xia Y; Sorrentino ZA; Kim JD; Strang KH; Riffe CJ; Giasson BI
    J Biol Chem; 2019 Nov; 294(48):18488-18503. PubMed ID: 31653695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments.
    Kaniyappan S; Tepper K; Biernat J; Chandupatla RR; Hübschmann S; Irsen S; Bicher S; Klatt C; Mandelkow EM; Mandelkow E
    Mol Neurodegener; 2020 Jul; 15(1):39. PubMed ID: 32677995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation.
    Xia Y; Bell BM; Giasson BI
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.